<DOC>
	<DOC>NCT00982514</DOC>
	<brief_summary>The study will examine the prevalence of venous thromboembolism in children with acute lymphoblastic leukaemia treated in accordance with NOPHO ALL-2008. The investigators will prospectively study clinical symptomatic thromboses, asymptomatic central line-associated thromboses, and infections.</brief_summary>
	<brief_title>Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Acute lymphoblastic leukaemia, Age 1 year to 16 years old, Central line, Protocol NOPHO ALL 2008. Refusal of participation, Treated according to protocol other than NOPHO ALL 2008.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Asparaginase</keyword>
	<keyword>thrombosis</keyword>
	<keyword>ALL</keyword>
	<keyword>central line</keyword>
</DOC>